Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

News SummaryMost relevantAll newsSector newsTweets 

GlaxoSmithKline plc : Director/PDMR Shareholding

share with twitter share with LinkedIn share with facebook
share via e-mail
05/03/2012 | 08:11pm CEST

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the interests of a Person Discharging Managerial Responsibility in the Ordinary Shares of GlaxoSmithKline plc ("Ordinary Shares") on 2 May 2012:

Mr S M Bicknell

Transfer of 250 Ordinary Shares into an ISA at £14.3225 per share.

The Company and the above mentioned person was advised of this transaction on 3 May 2012.

This notification relates to a transaction notified in accordance with Disclosure Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

3 May 2012

This information is provided by RNS
The company news service from the London Stock Exchange
distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
04/25 GLAXOSMITHKLINE : UK Conservatives hold 21 point lead over Labour in new poll
04/24 GLAXOSMITHKLINE : First malaria vaccine to be rolled out in Kenya
04/21 GLAXOSMITHKLINE : $3 million awarded to widow who sued pharmaceutical firm over ..
04/21 TEVA PHARMACEUTICAL INDUSTRIES LTD ( : TEVA) Asthma Inhaler To Compete With Glax..
04/21 GLAXOSMITHKLINE : $3M award in suit against drug company over man's suicide
04/21 GLAXOSMITHKLINE : Widow who sued pharmaceutical firm over husband's suicide awar..
04/21 Teva's new asthma inhaler poses first competition for GSK's Advair
04/20 GLAXOSMITHKLINE : Researchers from GlaxoSmithKline plc Detail New Studies and Fi..
04/20 GLAXOSMITHKLINE : Studies from GlaxoSmithKline plc Update Current Data on Pharma..
04/20 GLAXOSMITHKLINE : Data from GlaxoSmithKline plc Provide New Insights into Bradyk..
More news
Sector news : Pharmaceuticals - NEC
04/25DJSHIRE : Files 8K - Other Events
04/25DJSHIRE : Files 8K - Changes To Articles
04/25DJNasdaq Composite Tops 6000 for First Time
04/25DJASTRAZENECA : Lung Cancer Treatment Approved in EU
04/25DJELI LILLY AND : Working to Cut Costs
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
04/23 1st Quarter Portfolio Results - Better Than Expected
04/21 Teva Twin-Tracks Advair Competitor's Launch
04/21 EMA hands down a number of recommendations
04/21 Merck Leads Rivals In Novel Drug Approvals
04/20 What To Expect At GlaxoSmithKline's Q1/2017 Results
Financials ( GBP)
Sales 2017 30 029 M
EBIT 2017 8 357 M
Net income 2017 4 203 M
Debt 2017 14 127 M
Yield 2017 5,01%
P/E ratio 2017 19,89
P/E ratio 2018 16,94
EV / Sales 2017 3,09x
EV / Sales 2018 2,96x
Capitalization 78 628 M
More Financials
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Full-screen chart
Technical analysis trends GLAXOSMITHKLINE PLC
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 17,8  GBP
Spread / Average Target 11%
Consensus details
EPS Revisions
More Estimates Revisions
Emma Walmsley Chief Executive Officer & Executive Director
Philip Roy Hampton Non-Executive Chairman
Simon Dingemans Chief Financial Officer & Executive Director
Birgitte Volck Head-Research & Development
Moncef Slaoui Executive Director & Chairman-Global Vaccines
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON7.13%334 605
ROCHE HOLDING LTD.10.49%223 016
PFIZER INC.3.88%201 045
NOVARTIS AG2.16%199 772
MERCK & CO., INC.5.83%170 797
More Results